# A Study of Tirzepatide (LY3298176) in Pediatric Participants With Obesity

> **NCT05696847** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 28 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Tirzepatide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05696847
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-07
- **Primary completion:** 2025-01-16
- **Final completion:** 2025-01-16
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2025-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05696847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05696847, "A Study of Tirzepatide (LY3298176) in Pediatric Participants With Obesity". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05696847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*